CKP-25
CKP-25 is an inhibitor for the interaction between Spike RBD-ACE2, that prevents the virus from entering the host cell, thereby reducing the replication and virus infection. CKP-25 inhibits SARS-CoV-2 with IC50 of 3.5 μM in Vero E6 cell[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
COC1=CC=CC2=C1N=CN2CC3=CC(C=CC=C4)=C4C=C3
Molecular Formula
C19H16N2O
Molecular Weight
288.34
References & Citations
[1]Gkekas I, et al., AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors. J Chem Inf Model. 2024 Nov 25;64 (22) :8562-8585.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-15389R-APC-Cy5.5 100 µL
GPR180 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
